| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.008 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |